Anti-endothelial cell antibodies in systemic sclerosis

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 2, 1999, Pages 156-160

  Renaudineau, Yves ^a,b   Revelen, Ronan ^b   Levy, Yair ^a   Salojin, Konstantin ^c   Gilburg, Boris ^a   Shoenfeld, Yehuda ^a   Youinou, Pierre ^b,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY DETECTION; APOPTOSIS; AUTOIMMUNITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SCLERODERMA; SHORT SURVEY; SYSTEMIC SCLEROSIS; VASCULAR ENDOTHELIUM; VASCULITIS;

EID: 0033054652     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.2.156-160.1999     Document Type: Short Survey

References (62)

1. Adler, Y., K. Salojin, M. Le Tonquèze, Y. Shoenfeld, and P. Youinou. 1994. Anti-endothelial cell antibodies: a need for standardization. Lupus 3:77-84.
2. Boehme, M. W. J., W. H. Schmitt, P. Youinou, W. R. Stremmel, and W. L. Gross. 1996. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides. Am. J. Med. 101:387-394.
3. Bordron, A., M. Dueymes, Y. Levy, C. Jamin, J. P. Leroy, J. C. Piette, Y. Shoenfeld, and P. Youinou. 1998. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J. Clin. Investig. 101: 2029-2035.
4. Bordron, A., M. Dueymes, Y. Levy, C. Jamin, L. Ziporen, J. C. Piette, Y. Shoenfeld, and P. Youinou. 1998. Anti-endothelial cell antibody binding makes negatively-charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum. 41:1738-1747.
5. Carreras, L. G., and J. Vermylen. 1982. Lupus anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb. Haemostasis 48:38-40.
6. Carvalho, D., C. O. S. Savage, C. M. Black, and J. D. Pearson. 1996. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J. Clin. Investig. 97:111-119.
7. Chan, T. M., G. Frampton, N. A. Staines, P. Hobby, G. J. Perry, and J. S. Cameron. 1992. Different mechanisms by which anti-DNA MoAbs bind to human endothelial cell and glomerular mesangial cells. Clin. Exp. Immunol. 88:65-74.
8. Clements, P. J., and D. E. Furst (ed.). 1996. Systemic sclerosis. Williams & Wilkins, Baltimore, Md.
9. Cohen, S., A. R. Johnson, and E. Hurd. 1983. Cytotoxicity of sera from patients with scleroderma. Arthritis Rheum. 26:170-179.
10. Damianovich, M., B. Gilburd, J. George, N. Del Papa, A. Afek, I. Goldberg, Y. Kopolovic, D. Roth, G. Barkai, P. L. Meroni, and Y. Shoenfeld. 1996. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J. Immunol. 156:4946-4951.
11. Del Papa, N., G. Conforti, D. Gambini, L. La Rosa, A. Tincani, D. D'Cruz, M. A. Khamashta, G. R. V. Hughes, G. Balestrieri, and P. L. Meroni. 1994. Characterization of the endothelial surface proteins recognized by antiendothelial antibodies in primary and secondary autoimmune vasculitis. Clin. Immunol. Immunopathol. 70:211-216.
12. Del Papa, N., L. Guidali, M. Sironi, Y. Shoenfeld, A. Mantovani, A. Tincani, G. Balestrieri, A. Radice, A. Sinico, and P. L. Meroni. 1996. Antiendothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine expression. Arthritis Rheum. 39:758-766.
13. Del Papa, N., L. Guidali, A. Sala, C. Buccellati, M. A. Khamashta, K. Ichikawa, T. Koike, G. Balestrieri, A. Tincani, G. R. V. Hughes, and P. L. Meroni. 1997. Endothelial cells as target for antiphospholipid antibodies. Arthritis Rheum. 40:551-561.
14. Del Papa, N., P. L. Meroni, W. Barcellini, A. Sinico, A. Radice, A. Tincani, D. D'Cruz, F. Nicoletti, M. O. Borghi, M. A. Khamashta, G. R. V. Hughes, and G. Balestrieri. 1992. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin. Immunol. Immunopathol. 63:267-274.
15. Denton, C. P., S. Xu, K. I. Welsh, J. D. Pearson, and C. M. Black. 1996. Scleroderma fibroblast phenotype is modulated by endothelial cell coculture. J. Rheumatol. 23:633-638.
16. Direskeneli, H., D. D'Cruz, M. A. Khamashta, and G. R. V. Hughes. 1994. Autoantibodies against EC, extracellular matrix, and human collagen type IV in patients with systemic vasculitis. Clin. Immunol. Immunopathol. 70: 206-210.
17. Drenk, F., and H. R. G. Deicher. 1988. Pathophysiological effects of endothelial cytotoxic activity derived from sera of patients with progressive systemic sclerosis. J. Rheumatol. 15:468-474.
18. Dueymes, M., Y. Levy, R. Revelen, C. Jamin, L. Ziporen, J. C. Piette, Y. Shoenfeld, and P. Youinou. 1997. Antiendothelial cell antibody binding makes negatively-charged phospholipids accessible to antiphospholipid antibodies on the surface of endothelial cells. Ann. Med. Interne 148:42. (Abstract.)
19. Edgell, C. J. S., C. C. McDonald, and J. B. Graham. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80:3734-3737.
20. Finch, W. R., G. P. Rodman, R. B. Buckingham, R. K. Prince, and A. Winkelstein. 1980. Bleomycin induced scleroderma. J. Rheumatol. 7:651-659.
21. Gruschwitz, M. S., O. P. Hornstein, and P. von den Driesch. 1995. Correlation of soluble adhesion molecules in peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum. 38:237-242.
22. Hashemi, S., C. D. Smith, and C. A. Izaguirre. 1987. Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay. J. Lab. Clin. Med. 109:434-440.
23. Hasselaar, P., R. H. W. M. Derksen, J. D. Oosting, and L. Blokzijl. 1989. Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells. Thromb. Haemostasis 62:654-660.
24. Hebbar, M., P. Lassalle, A. Janin, D. Vanhee, S. Bisiau, P. Y. Hatron, A. B. Tonnel, and B. Gosselin. 1995. E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor alpha. Arthritis Rheum. 38:406-412.
25. Herrick, A. L., K. Illingworth, A. Blann, C. R. M. Hay, S. Hollis, and M. I. V. Jayson. 1996. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud phenomenon and systemic sclerosis. Ann. Rheum. Dis. 55:122-127.
26. Hill, M. B., J. L. Phipps, R. J. Cartwright, A. Milford Ward, M. Greaves, and P. Hughes. 1996. Antibodies to membranes of endothelial cells and fibroblasts in scleroderma. Clin. Exp. Immunol. 106:491-497.
27. Holt, C. M., N. Lindsey, J. Moult, R. G. Malia, M. Greaves, A. Hume, N. R. Rowell, and P. Hughes. 1989. Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin. Exp. Immunol. 78:359-365.
28. Ishikawa, H., Y. Saito, A. Yamakage, and M. Kitabatake. 1978. Scleroderma-inducing glycosaminoglycan in the urine of patients with systemic scleroderma. Dermatologica 156:193-204.
29. Jaffe, C. A. 1987. Cell biology of endothelial cells. Hum. Pathol. 18:234-239.
30. Kadono, T., K. Kikuchi, M. Kubo, M. Fujimoto, and K. Tamaki. 1996. Serum concentrations of basic fibroblast growth factor in collagen diseases. J. Am. Acad. Dermatol. 35:392-397.
31. Kahaleh, M. B., G. K. Sherer, and E. C. Leroy. 1979. Endothelial injury in scleroderma. J. Exp. Med. 149:1326-1335.
32. Le Tonquèze, M., C. Jamin, M. Boehme, R. Le Corre, M. Dueymes, and P. Youinou. 1996. Establishment and characterization of permanent endothelial cell clones. Lupus 5:103-112.
33. Lindquist, K. J., and C. K. Osterland. 1971. Human antibodies to vascular endothelium. Clin. Exp. Immunol. 9:753-760.
34. Marks, R. M., M. Czerniecki, B. S. Andrews, and R. Penny. 1988. The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity. Arthritis Rheum. 31:1524-1534.
35. Matucci-Cerinic, M., A. Pignone, and T. Lotti. 1990. Reduced angiotensin enzyme plasma activity in scleroderma. A marker of endothelial injury? J. Rheumatol. 17:328-330.
36. Meroni, P. L. 1997. What is going to happen tomorrow in the field of antiendothelial cell antibodies related to vasculitis. Ann. Med. Interne 145: 467-468.
37. Meroni, P. L., and P. Youinou. 1996. Endothelial cell antibodies, p. 245-252. In J. B. Peter and Y. Shoenfeld (ed.), Autoantibodies. Elsevier Science, Amsterdam, The Netherlands.
38. Meyer, O., T. Haim, A. Dryll, J. Lansaman, and A. Ryckewaert. 1983. Vascular endothelial cell injury in progressive systemic sclerosis and other connective tissue diseases. Clin. Exp. Rheumatol. 1:29-34.
39. Nagi, V. S., N. K. Tripathy, R. Misra, and S. Nityanand. 1998. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J. Rheumatol. 25:461-465.
40. Page, A., M. Rose, M. Yacoub, and R. Pigott. 1992. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141:673-683.
41. Penning, C. A., J. Cunningham, M. A. French, G. Harrison, N. R. Rowell, and P. Hughes. 1984. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin. Exp. Immunol. 57:548-556.
42. Penning, C. A., M. A. H. French, N. R. Rowell, and P. Hughes. 1985. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus. J. Clin. Lab. Immunol. 17:125-130.
43. Pignone, A., C. Scaletti, M. Matucci-Cerinic, D. Vazquez-Abad, P. L. Merone, N. Del Papa, F. Falcini, S. Generini, N. Rothfield, and M. Cagnoni. 1998. Anti-endothelial cell antibodies in systemic sclerosis: significant association with a vascular involvement and alveolo-capillary impairment. Clin. Exp. Rheumatol. 16:527-532.
44. Prescott, R. J., A. J. Freemont, C. J. P. Jones, J. Hoyland, and P. Fielding. 1992. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J. Pathol. 166:255-263.
45. Reitamo, S., A. Remitz, J. Varga, M. Ceska, F. Effenberger, S. Jimenez, and J. Uitto. 1993. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in serum of patients with systemic sclerosis and related disorders. Arch. Dermatol. 129:189-193.
46. Renaudineau, Y., R. Revelen, A. Bordron, D. Mottier, P. Youinou, and R. Le Corre. 1998. Two populations of endothelial cells antibodies cross-react with heparin. Lupus 7:86-94.
47. 46a. Renaudineau, Y., et al. Unpublished data.
48. Rosenbaum, J., B. E. Pottinger, P. Woo, C. M. Black, S. Loizou, M. A. Byron, and J. D. Pearson. 1988. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin. Exp. Immunol. 72:450-456.
49. Salojin, K. V., M. Le Tonqueze, A. Saraux, E. L. Nassonov, M. Dueymes, J. C. Piette, and P. Youinou. 1997. Antiendothelial cell antibodies: useful markers of systemic sclerosis. Am. J. Med. 102:178-185.
50. Sgonc, R., M. S. Gruschwitz, H. Dietrich, H. Recheis, M. E. Gershwin, and G. Wick. 1996. Endothelial cell apoptosis is a primary pathogenic event underlying skin lesions in avian and human scleroderma. J. Clin. Investig. 98: 785-792.
51. Shoenfeld, Y. 1994. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J. 8:1296-1303.
52. Shoenfeld, Y., and D. A. Isenberg (ed.). 1989. The mosaic of autoimmunity. Elsevier Science, Amsterdam, The Netherlands.
53. Sollberg, S., J. Peltonen, J. Uitto, and S. A. Jimenez. 1992. Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1 and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum. 35:290-298.
54. Stasny, P., and M. Ziff. 1967. Immunologically induced experimental models of human connective tissue disease. Rheumatology 1:198-205.
55. Tan, E. M., and C. M. Pearson. 1972. Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum. 15:23-28.
56. Tannenbaum, S. H., R. Finko, and D. B. Cines. 1986. Antibody and immune complexes induce tissue factor production by human endothelial cells. J. Immunol. 137:1532-1537.
57. van der Zee, J. M., A. H. Heurken, E. A. van de Voort, M. R. Daha, and K. C. Breedveld. 1991. Characterization of antiendothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin. Exp. Rheumatol. 9:589-595.
58. van der Zee, J. M., C. E. H. Siegert, T. A. De Vreede, M. R. Daha, and F. C. Breedveld. 1991. Characterization of antiendothelial cell antibodies in systemic lupus erythematosus. Clin. Exp. Immunol. 84:238-244.
59. Westphal, J. R., A. M. T. Boerbooms, C. J. M. Schalkwijk, H. Kwast, M. De Weijert, C. Jacobs, G. Vierwinden, D. H. Ruiter, L. B. A. van de Putte, and R. M. W. De Waal. 1994. Anti-EC antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysis. Clin. Exp. Immunol. 96:444-449.
60. Yamakage, A., and H. Ishikawa. 1982. Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Dermatologica 165: 186-193.
61. Youinou, P., P. L. Meroni, M. A. Khamashta, and Y. Shoenfeld. 1995. A need for standardization of the anti-endothelial cell antibody test. Immunol. Today 16:363-364.
62. Youinou, P. The pathogenic role of antiendothelial cell antibodies in systemic sclerosis. Clin. Exp. Rheumatol., in press.